BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4352385)

  • 1. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix.
    Rawls WE; Adam E; Melnick JL
    Cancer Res; 1973 Jun; 33(6):1477-82. PubMed ID: 4352385
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
    McDonald AD; Williams MC; Manfreda J; West R
    Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.
    Najem SN; Barton IG; Al-Omar LS; Potter CW
    Br J Exp Pathol; 1982 Oct; 63(5):485-9. PubMed ID: 6293526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of informal discussion of part 3 of genital herpesvirus and of in vivo animal studies.
    Rawls WE
    Cancer Res; 1973 Jun; 33(6):1511-4. PubMed ID: 4352390
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective studies of the association of genital herpes simplex infection and cervical anaplasia.
    Nahmias AJ; Naib ZM; Josey WE; Franklin E; Jenkins R
    Cancer Res; 1973 Jun; 33(6):1491-7. PubMed ID: 4352387
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correlations between herpesvirus and cervix carcinoma based on antigen-antibody studies].
    Sándor P; Lajos K; Béla P; Kálmán P
    Orv Hetil; 1975 Nov; 116(46):2711-5. PubMed ID: 172829
    [No Abstract]   [Full Text] [Related]  

  • 7. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. II. Uganda.
    Adam E; Sharma SD; Zeigler O; Iwamoto K; Melnick JL; Levy AH; Rawls WE
    J Natl Cancer Inst; 1972 Jan; 48(1):65-72. PubMed ID: 4347030
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiologic characteristics and virologic findings in women with precanceroses and carcinoma of the uterine cervix].
    Kanka J; Vonka V; Havránková A; Svoboda B; Váchal M; Subrt I; Hirsch I; Závadová H; Krcmár M; Broucek J
    Cesk Gynekol; 1985 Nov; 50(9):651-6. PubMed ID: 3002641
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls.
    Pacsa AS; Kummerländer L; Pejtsik B; Pali K
    J Natl Cancer Inst; 1975 Oct; 55(4):775-81. PubMed ID: 171424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. IV. Dysplasia and carcinoma in situ.
    Adam E; Kaufman RH; Melnick JL; Levy AH; Rawls WE
    Am J Epidemiol; 1973 Aug; 98(2):77-87. PubMed ID: 4724998
    [No Abstract]   [Full Text] [Related]  

  • 11. Relation of dysplasia and carcinoma of the uterine cervix to age at onset of sexual life and number of coital partners.
    Berget A
    Dan Med Bull; 1978 Aug; 25(4):172-6. PubMed ID: 688775
    [No Abstract]   [Full Text] [Related]  

  • 12. A population-based seroepidemiological study of cervical cancer.
    Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
    Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
    Feorino PM; Palmer EL
    J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents.
    Rotkin ID
    Cancer Res; 1973 Jun; 33(6):1353-67. PubMed ID: 4352371
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neutralizing antibodies to herpesvirus type 2 in the blood of women with genital cancer].
    Andonov P; Dundarov S; Iurkov K; Karag'ozov I
    Vopr Onkol; 1972; 18(4):54-8. PubMed ID: 4337597
    [No Abstract]   [Full Text] [Related]  

  • 18. Herpes simplex type 2 and cervical cancer: immunological and in situ hybridization studies.
    Simard R; Kessous A; Mansour M; Camonis J; Rawls WE
    Prog Clin Biol Res; 1983; 132D():461-9. PubMed ID: 6314363
    [No Abstract]   [Full Text] [Related]  

  • 19. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. I. Case-control matching.
    Adam E; Levy AH; Rawls WE; Melnick JL
    J Natl Cancer Inst; 1971 Nov; 47(5):941-51. PubMed ID: 4330800
    [No Abstract]   [Full Text] [Related]  

  • 20. [Herpes simplex virus type 2: its distribution and relationship to cervical carcinoma].
    Petersen EE; Böcker JR; Fürmaier I; Hillemanns HG
    Dtsch Med Wochenschr; 1972 Dec; 97(50):1936 passim. PubMed ID: 4344976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.